Results 131 to 140 of about 2,092,286 (303)
Probable ponatinib-induced papilledema in a patient with acute lymphocytic leukemia. [PDF]
Am J Ophthalmol Case Rep, 2023 Moon JA, Bowden EC, Aung MH.
europepmc +1 more source
A Case of Hodgkin Transformation of Chronic Lymphocytic Leukemia
, 2016 Richter’s transformation is a serious complication of chronic lymphocytic leukemia. We present a patient with Hodgkin transformation of chronic lymphocytic leukemia. This patient was admitted to our clinic with the complaints of weakness and fatigue. She
İlhami Kiki +5 more
core +1 more source
Tumour Antigen‐Specific Antibody Signatures as Diagnostic Biomarkers for Melanoma
International Journal of Cancer, EarlyView.ABSTRACT Early detection of melanoma remains challenging, and minimally invasive diagnostic tools are needed to complement imaging and histopathology. Circulating tumour antigen‐specific antibodies (Abs) are promising biomarkers, but their diagnostic value across melanoma stages is not fully established.
Cristina Vico‐Alonso +4 more
wiley +1 more source
Survival Rate of Patients with Acute Leukemia: A Case Study in Iran
Journal of Evidence Based Health Policy, Management & Economics, 2020 Background: Acute leukemia is a kind of aggressive disease that includes high rates of fatalities in the world, in particular in Iran. This research was done to determine the survival rate of patients with acute leukemia in Iran.
Mohammad Ranjbar +4 more
doaj
Meta-analysis of the p53 codon 72 Arg>Pro polymorphism on leukemia risk.
, 2012 aNumber of comparisons.bP value of Q-test for heterogeneity test.cOthers include acute lymphoblastic leukemia, chronic lymphocytic Leukemia, chronic myeloid leukemia.Abbreviations: AML, Acute myeloid leukemia.
Yu Weng (102970) +7 more
core +1 more source
International Journal of Cancer, EarlyView.ABSTRACT Chidamide is an oral histone deacetylase inhibitor whose use as early maintenance after allogeneic hematopoietic stem cell transplantation (HSCT) remains insufficiently defined. This prospective single‐center Phase 1/2 cohort included all 47 patients enrolled and treated by March 31, 2026.
Haonan Yang +9 more
wiley +1 more source
Metrnl: A Novel Therapeutic Target in Atherosclerosis
iNew Medicine, EarlyView.ABSTRACT Atherosclerosis is a chronic inflammatory vascular disease and the main pathological basis of cardiovascular and cerebrovascular events. Exploration of endogenous protective factors in the disease is beneficial for the establishment of new therapeutic strategies.
Pin Wang, Dao‐Xin Wang, Chao‐Yu Miao
wiley +1 more source
iNew Medicine, EarlyView.Using 18 global databases, this country‐level ecological study identified major positive and negative correlates of multiple myeloma prevalence and death rate, providing hypothesis‐generating evidence to inform future public health research and policy development.
Peng Xu +8 more
wiley +1 more source
SHP2 in Cancer: From Tumor Biology to Therapeutic Targeting
Medicinal Research Reviews, EarlyView.ABSTRACT SHP2 is a tyrosine phosphatase that mediates intracellular signaling downstream of transmembrane receptors regulated by a pair of src homology 2 (SH2) domains. Its overexpression and mutation are pivotal in driving tumor progression by influencing various cancer's fundamental characteristics, such as metastasis, DNA repair, angiogenesis ...
Maryam Jama +2 more
wiley +1 more source
Prenatal Diagnosis, EarlyView.ABSTRACT Sickle cell disease (SCD) affects millions worldwide but has limited treatment options, most of which carry significant side effects. At present, the only curative treatment for SCD is allogeneic or gene‐modified autologous hematopoietic stem cell (HSC) transplantation (Tx).
Oluwaseun O. Babatunde +4 more
wiley +1 more source